You have 9 free searches left this month | for more free features.

Estrogens, Conjugated (USP)

Showing 26 - 50 of 539

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7

Active, not recruiting
  • PSA Level Greater Than 0.03
  • +4 more
  • Antiandrogen Therapy
  • +2 more
  • Los Angeles, California
  • +1 more
Oct 14, 2021

Menopause Trial in Baton Rouge (TSEC (Tissue-selective estrogen complexes), Placebo)

Completed
  • Menopause
  • TSEC (Tissue-selective estrogen complexes)
  • Placebo
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Jan 19, 2022

Effect of ADT in Prostate Cancer Asia (READT Asia Study)

Recruiting
  • Prostate Cancer
  • Androgen deprivation therapy - bilateral orchidectomy
  • +2 more
  • Shatin, Hong Kong
    Prince of Wales Hospital
Dec 14, 2021

Overactive Bladder Trial in Maywood (conjugated estrogen)

Completed
  • Overactive Bladder
  • conjugated estrogen
  • Maywood, Illinois
    Loyola University Medical Center
Mar 22, 2021

Vaginitis Atropic, Pelvic Organ Prolapse, Endometrial Hyperplasia Trial (Conjugated Estrogen, Promestriene, Estriol)

Completed
  • Vaginitis Atropic
  • +2 more
  • Conjugated Estrogen
  • +3 more
  • (no location specified)
Apr 29, 2019

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Detroit, Petoskey

Completed
  • Stage I Prostate Adenocarcinoma
  • +2 more
  • Antiandrogen Therapy
  • +3 more
  • Detroit, Michigan
  • +2 more
Oct 4, 2020

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Anticoagulant Trial (Heparin)

Not yet recruiting
  • Anticoagulant
  • Heparin
  • (no location specified)
Mar 15, 2023

Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)

Not yet recruiting
  • Pneumococcal Vaccines
  • 12-Valent Pneumococcal Conjugate Vaccine
  • (no location specified)
Jan 31, 2023

Benign Prostatic Hyperplasia Trial in United States (Group-1 (15mg, OPK-88004), Group-2 (25 mg,OPK-88004), Placebo)

Terminated
  • Benign Prostatic Hyperplasia
  • Group-1 (15mg, OPK-88004)
  • +2 more
  • Anniston, Alabama
  • +14 more
Aug 23, 2021

Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

Active, not recruiting
  • Metastatic Breast Cancer
  • Springfield, Massachusetts
  • +2 more
Nov 1, 2022

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Ureter Injury Trial (Saline Injection 0.9%, Indigotindisulfonate sodium 0.8%)

Not yet recruiting
  • Ureter Injury
  • Saline Injection 0.9%
  • Indigotindisulfonate sodium 0.8%
  • (no location specified)
Oct 12, 2023

Menopausal Syndromes Trial in Banqiao (Tibolone, Estradiol & medroxyprogesterone acetate)

Completed
  • Menopausal Syndromes
  • Tibolone
  • Estradiol & medroxyprogesterone acetate
  • Banqiao, New Taipei, Taiwan
    Far Eastern Memorial Hospital
Feb 7, 2022

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Recurrent Urinary Tract Infection Trial in La Jolla, New York (Conjugated Estrogen Vaginal Cream, Estradiol Ring, Placebo)

Completed
  • Recurrent Urinary Tract Infection
  • Conjugated Estrogen Vaginal Cream
  • +2 more
  • La Jolla, California
  • +1 more
Aug 26, 2020

Cancer, Breast, Cancer, Lung, Cancer of Pancreas Trial in Fairfax, Beijing (CBP-1019)

Active, not recruiting
  • Cancer, Breast
  • +4 more
  • Fairfax, Virginia
  • +1 more
Apr 13, 2023

Breast Cancer Trial (Disitamab Vedotin+Anlotinib)

Not yet recruiting
  • Breast Cancer
  • Disitamab Vedotin+Anlotinib
  • (no location specified)
Aug 14, 2023

Ankle Osteoarthritis Trial in Astana (Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic

Recruiting
  • Ankle Osteoarthritis
  • Injection of biocomposite hydrogel into ankle's cartilage lesion under arthroscopic control
  • Microfracture of ankle's cartilage lesion under arthroscopic control
  • Astana, Kazakhstan
    Center of National Scientific center Of Traumatology and Orthope
Aug 31, 2023

Knee Osteoarthritis Trial in United States (Micronized DHACM, Saline)

Completed
  • Knee Osteoarthritis
  • Birmingham, Alabama
  • +16 more
May 20, 2022

Solid Tumor Trial in Worldwide (BYON3521)

Recruiting
  • Solid Tumor
  • Brussels, Belgium
  • +3 more
Aug 2, 2022

Cervical Cancer, Sexual Dysfunction, Quality of Life Trial in Barcelona, Madrid (Multimodal intervention on sexual dysfunction

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • Multimodal intervention on sexual dysfunction and quality-of-life
  • Barcelona, Spain
  • +1 more
Sep 4, 2023

Palliative Care in COVID-19: Analysis of Costs of

Not yet recruiting
  • COVID-19
  • Palliative Care
  • Analysis of costs with patient care during hospitalization
  • (no location specified)
Jun 12, 2023